1 Neoadjuvant Chemotherapy Reduces Colon Cancer Recurrence Rate By 28%, With Fewer Post-Operative Complications, Study Shows Nov 15, 2024
Read More Apparatus Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Nov 06, 2024
Read More Medical Good News, Orphan Drug Status Granted By The FDA For Ezurpimtrostat, a Cutting Edge Drug For Liver Cancer! Nov 11, 2024
Read More Medical UK Launches First Clinical Trial Of Proton Beam Therapy For Breast Cancer To Help Patients Reduce The Risk Of Heart Problems Caused By Radiotherapy Nov 17, 2024
